| Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol. | |
MedLine Citation:
|
PMID: 7243794 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Clofibrate (a very effective lipid-lowering drug) may cause serious muscular damage in uraemic patients, even if used at appropriately low dose. Some authors have reported that D,L-Carnitine and Thiadenol can reduce lipid levels in non uraemic subjects, without adverse effects. In our study D,L-Carnitine and Thiadenol were administered for 3 months to respectively 21 and 15 patients on chronic haemodialysis with hypertriglyceridaemia. With D,L-Carnitine 52% of patients showed lower plasma triglycerides (TG) (-40.6%, p less than 0.002); after Thiadenol 66.6% of patients showed reduced plasma TG concentration (-42.9%, p less than 0.001). No dietary changes were recorded during the study. No major side effects nor biochemical changes were observed. D,L-Carnitine and Thiadenol appear to be less effective, but also less dangerous than Clofibrate in chronic uraemic patients. |
Authors:
|
G Giorcelli; G Vacha; G P Icardi |
Related Documents
:
|
21784414 - Progressive brain change in schizophrenia: a prospective longitudinal study of first-ep... 21569454 - Reduced csf turnover and decreased ventricular aβ42 levels are related. 22310884 - Rhabdomyolysis after heterotopic ossification: an unusual complication in a spinal cord... 21862344 - Increased levels of cytokines and high-mobility group box 1 are associated with the dev... 24962264 - Evaluation of salivary function in patients with burning mouth syndrome. 2134574 - Gastrointestinal function, morphology, and immune status in uremia. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association Volume: 17 ISSN: 0071-2736 ISO Abbreviation: Proc Eur Dial Transplant Assoc Publication Date: 1980 |
Date Detail:
|
Created Date: 1981-08-10 Completed Date: 1981-08-10 Revised Date: 2008-02-21 |
Medline Journal Info:
|
Nlm Unique ID: 0355210 Medline TA: Proc Eur Dial Transplant Assoc Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 367-71 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carnitine
/
therapeutic use* Chronic Disease Clofibrate / therapeutic use Fatty Alcohols / therapeutic use* Humans Hyperlipoproteinemias / complications, drug therapy* Lipid Metabolism Renal Dialysis Uremia / complications* |
| Chemical | |
Reg. No./Substance:
|
0/Fatty Alcohols; 541-15-1/Carnitine; 637-07-0/Clofibrate; 6964-20-1/tiadenol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Serum levels of PTH, Mg, Ca, inorganic phosphate and alkaline phosphatases in uraemic patients on di...
Next Document: Risks and benefits of bilateral nephrectomy: an analysis of 134 cases.